Thierry Muron

477 total citations
16 papers, 106 citations indexed

About

Thierry Muron is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Thierry Muron has authored 16 papers receiving a total of 106 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in Thierry Muron's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal and Anal Carcinomas (4 papers). Thierry Muron is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal and Anal Carcinomas (4 papers). Thierry Muron collaborates with scholars based in France, China and United Kingdom. Thierry Muron's co-authors include Jean‐Baptiste Guy, Guy de Laroche, Nicolas Magné, Julien Langrand-Escure, Jack Porcheron, G. Ganem, Mireille Mousseau, Emmanuel Achille, Élisabeth Carola and David Kaczmarek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stroke.

In The Last Decade

Thierry Muron

15 papers receiving 103 citations

Peers

Thierry Muron
Svilen Maslyankov Bulgaria
Tony Philip United States
Arantza López de Munain Spain
Brian C. Boulmay United States
Priyank Patel United States
A. Bardet France
Mohsen Al Zahrani Saudi Arabia
Roberta Grande Italy
Moto Yaga Japan
Leonor Vasconcelos de Matos Portugal
Svilen Maslyankov Bulgaria
Thierry Muron
Citations per year, relative to Thierry Muron Thierry Muron (= 1×) peers Svilen Maslyankov

Countries citing papers authored by Thierry Muron

Since Specialization
Citations

This map shows the geographic impact of Thierry Muron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Muron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Muron more than expected).

Fields of papers citing papers by Thierry Muron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Muron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Muron. The network helps show where Thierry Muron may publish in the future.

Co-authorship network of co-authors of Thierry Muron

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Muron. A scholar is included among the top collaborators of Thierry Muron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Muron. Thierry Muron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tissot, Claire, Thierry Muron, David Kaczmarek, et al.. (2022). Adjuvant chemotherapy for completely resected IIA–IIIA non-small cell lung cancer: compliance to guidelines, safety and efficacy in real-life practice. Translational Lung Cancer Research. 11(12). 2418–2437. 4 indexed citations
2.
Groh, Matthieu, Laura Venditti, Émilie Chalayer, et al.. (2021). FIP1L1-PDGFRA-Associated Hypereosinophilic Syndrome as a Treatable Cause of Watershed Infarction. Stroke. 52(10). e605–e609. 5 indexed citations
3.
Bouleftour, Wafa, Thierry Muron, Aline Guillot, et al.. (2021). Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study). Supportive Care in Cancer. 29(8). 4257–4267. 11 indexed citations
4.
Langrand-Escure, Julien, Guoping Wang, Jean‐Baptiste Guy, et al.. (2018). Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional survey. Scientific Reports. 8(1). 10708–10708. 12 indexed citations
5.
Vallard, Alexis, Sophie Espenel, Guy de Laroche, et al.. (2018). Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker. Oncotarget. 9(32). 22368–22382. 18 indexed citations
6.
7.
Oriol, Mathieu, Fabien Tinquaut, Thierry Muron, et al.. (2016). Validation d’un questionnaire mesurant l’adhérence et les compétences de gestion des effets secondaires chez des patients traités par capécitabine. Bulletin du Cancer. 103(3). 241–251. 2 indexed citations
8.
9.
André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC*. Bulletin du Cancer. 93(2). 5–9. 1 indexed citations
10.
André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). [Adjuvant treatment of colon cancer MOSAIC study's main results].. PubMed. 93 Suppl 1. S5–9. 36 indexed citations
11.
Piedbois, Pascal, Thierry André, J.-Y. Douillard, et al.. (2004). 5FU-leucovorin (5FU/LV) with or without irinotecan (CPT-11) in stages II-III rectal cancers: Preliminary safety analysis of the French Intergroup R98 phase III trial. Journal of Clinical Oncology. 22(14_suppl). 3549–3549. 2 indexed citations
12.
Bachelot, Thomas, Isabelle Ray‐Coquard, David Coeffic, et al.. (2002). [Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].. PubMed. 89(10). 897–903. 2 indexed citations
13.
Muron, Thierry, et al.. (1994). Photo quiz. Orf.. PubMed. 19(2). 257, 349–257, 349. 1 indexed citations
14.
15.
Muron, Thierry, et al.. (1993). [Stereotactic radiosurgery. Preliminary experience of a team of Lyon].. PubMed. 144(1). 9–14. 8 indexed citations
16.
Muron, Thierry, et al.. (1991). [Ideal treatment of malaria attack: more questions than answers? Experience of a department of infectious diseases].. PubMed. 142(4). 254–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Svilen Maslyankov Breakdown of academic impact, for papers by Tony Philip Breakdown of academic impact, for papers by Arantza López de Munain Breakdown of academic impact, for papers by Brian C. Boulmay Breakdown of academic impact, for papers by Priyank Patel Breakdown of academic impact, for papers by A. Bardet Breakdown of academic impact, for papers by Mohsen Al Zahrani Breakdown of academic impact, for papers by Roberta Grande Breakdown of academic impact, for papers by Moto Yaga Breakdown of academic impact, for papers by Leonor Vasconcelos de Matos
Rankless by CCL
2026